SAREPTA THERAPEUTICS, INC. Notes Payable, Current
SAREPTA THERAPEUTICS, INC. (SRPT) had Notes Payable, Current of $2.49 million as of 2015-12-31, per its 10-K filed 2017-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:NotesPayableCurrent · last filed 2017-02-28
- 2015-12-31: Notes Payable, Current $2.49M.
- 2015-09-30: Notes Payable, Current $2.45M.
- 2015-06-30: Notes Payable, Current $4.91M.
- 2015-03-31: Notes Payable, Current $4.83M.
| Period end | Notes Payable, Current |
|---|---|
| 2015-12-31 | $2.49M 10-K · filed 2017-02-28 |
| 2015-09-30 | $2.45M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $4.91M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $4.83M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $2.49M 10-K · filed 2016-02-25 |
| 2014-09-30 | $2.42M 10-Q · filed 2014-11-06 |
| 2013-12-31 | $0.00 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |